Krisflu M 5mg/10mg Tablet is a combination medication containing Levocetirizine 5mg and Montelukast 10mg, indicated for the management of allergic conditions such as allergic rhinitis and chronic urticaria. Levocetirizine, a third-generation non-sedating antihistamine, selectively inhibits peripheral H1 receptors, thereby alleviating symptoms like sneezing, nasal congestion, itching, and rhinorrhea by preventing histamine-induced allergic responses. Montelukast, a leukotriene receptor antagonist, blocks cysteinyl leukotriene receptors (CysLT1), reducing inflammation, bronchoconstriction, and mucus production associated with allergic airway diseases. The synergistic action of these agents provides comprehensive relief from both immediate and delayed allergic symptoms. Krisflu M is particularly beneficial in patients with concomitant allergic rhinitis and asthma, improving respiratory function and quality of life. It is administered orally, typically once daily in the evening, and should be used under medical supervision. Common adverse effects may include headache, fatigue, and gastrointestinal disturbances, though the combination is generally well tolerated. Caution is advised in patients with hepatic or renal impairment. This fixed-dose combination offers an effective therapeutic option for patients requiring dual antihistaminic and antileukotriene therapy to control persistent allergic manifestations.

Dosage & How to Use